Findings

What do systematic reviews say?

43 questions · 43 findings · 2 reviews · Movement Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 6 · 14%Very low 0 · 0%Low 1 · 2.3%Moderate 19 · 44.2%High 17 · 39.5%

BoNT‐A/OT vs BoNT‐A only

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
High

BoNT‐A/OT vs BoNT‐A only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A vs placebo/no treatment

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Moderate

BoNT‐A vs placebo/no treatment

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Moderate

BoNT‐A vs placebo/no treatment

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

BoNT‐A vs placebo/no treatment

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
High

BoNT‐A vs placebo/no treatment

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
High

High dose BoNT‐A vs Low dose BoNT‐A

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
GRADE not reported

High dose BoNT‐A vs Low dose BoNT‐A

Wrist flexor spasticity · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
GRADE not reported

High dose BoNT‐A vs Low dose BoNT‐A

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

High dose BoNT‐A vs Low dose BoNT‐A

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
GRADE not reported

High dose BoNT‐A vs Low dose BoNT‐A

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
GRADE not reported

High dose BoNT‐A vs Low dose BoNT‐A

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
GRADE not reported